The price of methylprednisolone acetate can vary widely depending on factors such as dosage, formulation, brand versus generic status, and the pharmacy or healthcare provider.
How much does methylprednisolone acetate cost?
Without insurance, a single vial of methylprednisolone acetate injection can range from approximately $10 to over $50, with higher concentrations or specific branded formulations potentially costing more. For example, a 40 mg/mL vial might be priced around $20-$30, while a 125 mg vial could be $50 or higher. These prices are estimates and are subject to change.
What influences the cost of methylprednisolone acetate?
The cost is influenced by several elements. Generic versions are generally less expensive than brand-name products. Injectable formulations often come in pre-filled syringes or vials, with costs varying based on volume and concentration. The specific indication for use, such as intra-articular injection for joint inflammation versus intramuscular administration, may also affect pricing.
How does insurance affect methylprednisolone acetate pricing?
Insurance coverage significantly impacts out-of-pocket expenses. Most insurance plans cover methylprednisolone acetate, but the co-pay amount will depend on the specific plan's formulary and deductible. Patients may have different costs for generic versus brand-name drugs even with insurance.
Where can I find pricing for methylprednisolone acetate?
Pricing information can be obtained from various sources. Pharmacies, including online and brick-and-mortar retailers, list their prices for the medication. Healthcare providers' offices can also provide cost estimates for treatments involving methylprednisolone acetate. Websites that compare drug prices can offer further insights, though availability and exact pricing can differ by location.
What are the different types of methylprednisolone acetate formulations?
Methylprednisolone acetate is available in several forms, primarily as an injectable suspension for intramuscular, intra-articular, intralesional, and intrasynovial administration. It is also found in ophthalmic suspension and cream formulations for topical use, though the question likely refers to the injectable form used for systemic or localized inflammatory conditions.
Who makes methylprednisolone acetate?
Several pharmaceutical manufacturers produce methylprednisolone acetate. These include both originator companies for branded versions and generic manufacturers. Companies like Pfizer (brand name Depo-Medrol) and various generic drug companies supply the market.
When is patent protection for methylprednisolone acetate relevant?
While the original patents for methylprednisolone acetate have long expired, leading to widespread generic availability, any new formulations, delivery systems, or specific uses of the drug could be subject to new patent filings. DrugPatentWatch.com provides data on pharmaceutical patents and exclusivity periods.